AWM Investment Company, Inc. 13D and 13G filings for OncoCyte Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 3:47 pm Purchase |
2023-12-31 | 13G | OncoCyte Corporation OCX |
AWM Investment Company, Inc. | 754,286 9.100% |
391,575 (+107.96%) |
Filing |
| 2023-02-14 11:23 am Purchase |
2022-12-31 | 13G | OncoCyte Corporation OCX |
AWM Investment Company, Inc. | 362,711 6.100% |
362,711 (New Position) |
Filing |